Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Sep-24 6:04 AM View:  | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 26-Sep-24 | Private Purchase | 1,500 | $14.63 | $21,945.00 | < 1% 5.53M to 5.54M | |
| 16-Sep-24 6:05 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 12-Aug-24 | Private Purchase | 800 | $13.85 | $11,080.00 | < 1% 262.35K to 263.15K | |
| 08-Aug-24 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 06-Aug-24 | Private Purchase | 2,000 | $13.81 | $27,620.00 | < 1% 5.53M to 5.53M | |
| 07-Aug-24 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 05-Aug-24 | Private Purchase | 5,500 | $13.18 | $72,490.00 | < 1% 5.53M to 5.53M | |
| 05-Aug-24 6:05 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 02-Aug-24 | Private Purchase | 1,000 | $15.15 | $15,150.00 | < 1% 261.35K to 262.35K | |
| 24-Jul-24 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 23-Jul-24 | Private Purchase | 1,500 | $15.89 | $23,835.00 | < 1% 5.53M to 5.53M | |
| 22-Jul-24 6:05 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 18-Jul-24 | Private Purchase | 1,000 | $16.00 | $16,000.00 | < 1% 260.35K to 261.35K | |
| 17-Jun-24 6:10 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 13-Jun-24 | Private Purchase | 174,825 | $14.30 | $2,500,000.00 | 3% 5.35M to 5.53M | |
| 03-Apr-24 6:10 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 01-Apr-24 | Private Purchase | 3,000 | $19.08 | $57,240.00 | < 1% 5.35M to 5.35M | |
| 26-Mar-24 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 22-Mar-24 | Market Purchase | 2,500 | $19.98 | $49,950.00 | < 1% 5.35M to 5.35M | 6% |
| 22-Mar-24 6:02 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 20-Mar-24 | Private Purchase | 1,500 | $17.68 | $26,520.00 | < 1% 5.34M to 5.35M | |
| 07-Mar-24 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 05-Mar-24 | Private Purchase | 30,500 | $12.49 | $380,945.00 | < 1% 5.31M to 5.34M | |
| 06-Mar-24 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 04-Mar-24 | Private Purchase | 4,100 | $13.03 | $53,423.00 | < 1% 5.34M to 5.34M | |
| 21-Feb-24 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 16-Feb-24 | Private Purchase | 10,800 | $11.16 | $120,528.00 | < 1% 5.33M to 5.34M | |
| 20-Feb-24 6:04 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 15-Feb-24 | Private Purchase | 12,700 | $11.07 | $140,589.00 | < 1% 5.31M to 5.33M | |
| 14-Nov-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 10-Nov-23 | Private Purchase | 5,000 | $10.17 | $50,837.50 | < 1% 5.31M to 5.31M | |
| 07-Nov-23 6:15 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 03-Nov-23 | Private Purchase | 3,500 | $9.11 | $31,885.00 | < 1% 5.3M to 5.31M | |
| 31-Oct-23 6:16 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 27-Oct-23 | Private Purchase | 500 | $8.57 | $4,285.00 | < 1% 259.85K to 260.35K | |
| 30-Oct-23 6:15 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 26-Oct-23 | Private Purchase | 2,500 | $7.97 | $19,925.00 | < 1% 5.3M to 5.3M | |
| 27-Oct-23 6:15 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 25-Oct-23 | Private Purchase | 2,500 | $7.91 | $19,775.00 | < 1% 5.3M to 5.3M | |
| 12-Oct-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 10-Oct-23 | Private Purchase | 1,000 | $9.07 | $9,070.00 | < 1% 5.3M to 5.3M | |
| 05-Oct-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 04-Oct-23 | Private Purchase | 2,000 | $8.63 | $17,260.00 | < 1% 5.3M to 5.3M | |
| 28-Sep-23 6:05 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 26-Sep-23 | Private Purchase | 600 | $8.71 | $5,226.00 | < 1% 259.25K to 259.85K | |
| 21-Sep-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 19-Sep-23 | Private Purchase | 4,000 | $8.95 | $35,800.00 | < 1% 5.29M to 5.3M | |
| 13-Sep-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 11-Sep-23 | Private Purchase | 1,000 | $9.48 | $9,480.00 | < 1% 5.29M to 5.29M | |
| 24-Aug-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 22-Aug-23 | Private Purchase | 1,000 | $9.97 | $9,970.00 | < 1% 5.29M to 5.29M | |
| 08-Aug-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 04-Aug-23 | Private Purchase | 2,000 | $10.55 | $21,100.00 | < 1% 5.29M to 5.29M | |
| 25-Jul-23 6:15 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 21-Jul-23 | Private Purchase | 1,000 | $9.20 | $9,200.00 | < 1% 5.29M to 5.29M | |
| 17-Jul-23 6:15 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 13-Jul-23 | Private Purchase | 250 | $9.49 | $2,372.50 | < 1% 259.0K to 259.25K | |
| 18-May-23 6:01 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 17-May-23 | Private Purchase | 1,000 | $11.69 | $11,690.00 | < 1% 5.29M to 5.29M | |
| 02-May-23 6:06 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 28-Apr-23 | Private Purchase | 250 | $11.22 | $2,805.00 | < 1% 258.75K to 259.0K | |
| 21-Apr-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 19-Apr-23 | Private Purchase | 7,000 | $11.10 | $77,700.00 | < 1% 5.28M to 5.29M | |
| 20-Apr-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 18-Apr-23 | Private Purchase | 2,000 | $11.12 | $22,240.00 | < 1% 5.28M to 5.28M | |
| 12-Apr-23 6:02 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 11-Apr-23 | Private Purchase | 5,000 | $12.42 | $62,100.00 | < 1% 5.27M to 5.27M | |
| 12-Apr-23 6:05 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 11-Apr-23 | Private Purchase | 1,000 | $11.87 | $11,870.00 | < 1% 257.75K to 258.75K | |
| 16-Mar-23 6:05 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 15-Mar-23 | Private Purchase | 250 | $12.71 | $3,177.50 | < 1% 257.5K to 257.75K | |
| 13-Mar-23 7:15 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 10-Mar-23 | Private Purchase | 1,000 | $12.12 | $12,120.00 | < 1% 2.74M to 2.74M | |
| 28-Feb-23 6:03 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 24-Feb-23 | Private Purchase | 250 | $15.40 | $3,848.75 | < 1% 257.25K to 257.5K | |
| 22-Feb-23 6:07 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 17-Feb-23 | Private Purchase | 600 | $16.53 | $9,918.00 | < 1% 2.74M to 2.74M | |
| 14-Feb-23 6:08 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 10-Feb-23 | Private Purchase | 1,000 | $18.68 | $18,680.00 | < 1% 2.73M to 2.74M | |
| 07-Feb-23 6:10 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 03-Feb-23 | Market Purchase | 250 | $20.84 | $5,210.00 | < 1% 257.0K to 257.25K | 2% |
| 30-Jan-23 6:15 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 27-Jan-23 | Private Purchase | 250 | $19.20 | $4,800.00 | < 1% 256.75K to 257.0K | |
| 31-Jan-23 6:15 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 27-Jan-23 | Private Purchase | 2,000 | $19.35 | $38,700.00 | < 1% 2.73M to 2.73M | |
| 24-Jan-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 20-Jan-23 | Private Purchase | 1,500 | $17.37 | $26,055.00 | < 1% 2.73M to 2.73M | |
| 17-Jan-23 6:02 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 13-Jan-23 | Private Purchase | 250 | $16.50 | $4,125.00 | < 1% 256.5K to 256.75K | |
| 10-Jan-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 06-Jan-23 | Private Purchase | 1,500 | $15.18 | $22,770.00 | < 1% 2.73M to 2.73M | |
| 03-Jan-23 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 29-Dec-22 | Private Purchase | 4,000 | $15.19 | $60,760.00 | < 1% 2.73M to 2.73M | |
| 20-Dec-22 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 16-Dec-22 | Private Purchase | 1,000 | $13.01 | $13,010.00 | < 1% 2.72M to 2.73M | |
| 20-Dec-22 6:05 AM View: | Thompson Jaye VP Clinical Reg Affairs | Greenwich Lifesciences, Inc. (GLSI) | 16-Dec-22 | Private Purchase | 250 | $12.94 | $3,235.00 | < 1% 256.25K to 256.5K | |
| 13-Dec-22 6:05 AM View: | Patel Snehal CEO and CFO Director 10% Owner | Greenwich Lifesciences, Inc. (GLSI) | 09-Dec-22 | Private Purchase | 2,000 | $13.11 | $26,220.00 | < 1% 2.72M to 2.72M |
